SEC 13F Intelligence

Edgar Lomax Co/Va / PFE

Edgar Lomax Co/Va’s Pfizer Inc Position

Does Edgar Lomax Co/Va own Pfizer Inc (PFE)? Yes — 1.45M shares worth $41M (+2.90% of its 13F portfolio) as of Q1 2026, up from 592.3K shares the prior filed quarter.

Position Value
$41M
Q1 2026
Shares
1.45M
% of Portfolio
+2.90%
Quarters Held
30
currently held

Position History PFE

Reported value by quarter
Q4 ’18: $69MQ4 ’18Q1 ’19: $63MQ2 ’19: $64MQ3 ’19: $52MQ4 ’19: $56MQ4 ’19Q1 ’20: $57MQ2 ’20: $58MQ3 ’20: $68MQ4 ’20: $67MQ4 ’20Q1 ’21: $29MQ2 ’21: $31MQ3 ’21: $33MQ4 ’21: $45MQ4 ’21Q1 ’22: $38MQ2 ’22: $39MQ3 ’22: $47MQ4 ’22: $55MQ4 ’22Q1 ’23: $42MQ2 ’23: $37MQ3 ’23: $33MQ4 ’23: $27MQ4 ’23Q1 ’24: $42MQ2 ’24: $42MQ3 ’24: $43MQ4 ’24: $38MQ4 ’24Q1 ’25: $20MQ2 ’25: $19MQ3 ’25: $16MQ4 ’25: $15MQ4 ’25Q1 ’26: $41Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.45M$41M+2.90%
Q4 2025592.3K$15M+1.12%
Q3 2025610.0K$16M+1.22%
Q2 2025792.5K$19M+1.22%
Q1 2025805.4K$20M+1.28%
Q4 20241.43M$38M+2.45%
Q3 20241.47M$43M+2.59%
Q2 20241.49M$42M+2.71%
Q1 20241.51M$42M+2.59%
Q4 2023948.3K$27M+1.78%
Q3 2023991.7K$33M+2.24%
Q2 20231.01M$37M+2.44%
Q1 20231.02M$42M+2.69%
Q4 20221.08M$55M+3.34%
Q3 20221.08M$47M+3.27%
Q2 2022751.9K$39M+2.47%
Q1 2022731.0K$38M+2.22%
Q4 2021765.7K$45M+2.71%
Q3 2021773.1K$33M+2.13%
Q2 2021788.5K$31M+1.92%
Q1 2021801.6K$29M+1.81%
Q4 20201.82M$67M+4.54%
Q3 20201.85M$68M+5.23%
Q2 20201.78M$58M+4.65%
Q1 20201.74M$57M+5.05%
Q4 20191.43M$56M+3.60%
Q3 20191.45M$52M+3.49%
Q2 20191.47M$64M+4.33%
Q1 20191.49M$63M+4.35%
Q4 20181.57M$69M+5.21%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Edgar Lomax Co/Va’s full portfolio or all institutional holders of PFE.